This innovative 3D bioprinting technology will be offered to third parties by a wholly owned private MeaTech subsidiary as an additional revenue stream and to accelerate commercialization
From cells to real meat
This innovative 3D bioprinting technology will be offered to third parties by a wholly owned private MeaTech subsidiary as an additional revenue stream and to accelerate commercialization